
05 April, 2019
Scientists develop all in one immunotherapy for HIV, where engineered dendritic cells (MDC1) target CMV infected cells - which bring latent HIV out of hiding - MDC1 then recruits T helper cells to kill the infected cells

Labels:
Science
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment